Monica Barbolini

615 citations
26 papers · 399 indexed · h-index 9

Monica Barbolini

21 papers receiving 395 citations

Peers

Monica Barbolini
Comparison fields: 5 of 56
  • Oncology 254
  • Pathology and Forensic Medicine 130
  • Molecular Biology 127
  • Cancer Research 117
  • Pulmonary and Respiratory Medicine 96
Replace Levi Sokol with:
Levi Sokol United States
Shaham Beg Saudi Arabia
Alessia Tacito Italy
Federica Panebianco United States
Javier Pozas Spain
Cristina Smolenschi France
María San Román Spain
Chiara Brando Italy
Marco Brugia Italy
Laura Demurtas Italy
Monica Barbolini relative to Levi Sokol United States Levi Sokol's profile →
Citations per field
00.5×2.8×
Levi Sokol · 1×
Citations per year

Countries citing papers authored by Monica Barbolini

Since Specialization
Citations

This map shows the geographic impact of Monica Barbolini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Barbolini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Barbolini more than expected).

Fields of papers citing papers by Monica Barbolini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica Barbolini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Barbolini. The network helps show where Monica Barbolini may publish in the future.

Co-authorship network of co-authors of Monica Barbolini

This figure shows the co-authorship network connecting the top 25 collaborators of Monica Barbolini. A scholar is included among the top collaborators of Monica Barbolini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica Barbolini. Monica Barbolini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 1
4 58
5 0
6 0
7 9
8 6
9 9
10 1
11 8
12 5
13
Clinical Prognosticators in Patients Treated with CDK 4/6 Inhibitors for Hormone Receptors Positive Advanced Breast Cancer
1
14 4
15 8
16 20
17 5
18 1
19 8
20 206

About Monica Barbolini

Monica Barbolini is a scholar working on Cancer Research, Anatomy and Oncology, having authored 26 papers that have together received 399 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (12 papers), Breast Cancer Treatment Studies (9 papers) and HER2/EGFR in Cancer Research (6 papers). The work is most often cited by research in Oncology (254 citations), Cancer Research (117 citations) and Pathology and Forensic Medicine (130 citations). Monica Barbolini has collaborated with scholars based in Italy, United Kingdom and Netherlands. Frequent co-authors include Stefano Cascinu, Fabio Gelsomino, Andrea Spallanzani, Giuseppe Pugliese, Federico Piacentini, Claudia Omarini, Massimo Dominici, Luca Moscetti, Federica Caggia and Krisida Cerma. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026